Market Outlook


  • Brookstone CEO on the Latest Products     Tuesday, 11 Dec 2012 | 11:51 AM ET

    Brookstone CEO Stephen Bebis discusses why consumers like his products, and displays some current hot products. "Our products improve your quality of life," he says.

  • Technicals of Apple, Microsoft     Tuesday, 11 Dec 2012 | 11:23 AM ET

    Taking a technical look at the charts of Apple and Microsoft, with Tom McClellan, The McClellan Market Report editor, and CNBC's Gary Kaminsky.

  • Tech Giants & Their Overseas Cash     Tuesday, 11 Dec 2012 | 11:19 AM ET

    Just how much cash is in overseas bank accounts that are not subject to U.S. taxes? CNBC's Jon Fortt reports the details.

  • Protecting Your Portfolio     Tuesday, 11 Dec 2012 | 10:49 AM ET

    Checking on the markets, with Chuck Gabriel, Capital Alpha Partners, and Andy Laperriere, ISI Group. The quality of any deal between the President and Congress will determine the direction of the markets.

  • RBC: More Housing Upside in 2013     Tuesday, 11 Dec 2012 | 10:20 AM ET

    RBC Capital Markets is out with its 2013 housing market outlook this morning. RBC's Robert Wetenhall breaks down the report.

  • CNBC Fed Survey: QE & the Economy     Tuesday, 11 Dec 2012 | 10:15 AM ET

    CNBC's Steve Liesman reports what participants of the CNBC Fed survey say about the probability of a recession, and the dangers of the looming fiscal cliff.

  • Delivering Alpha to Pensions     Tuesday, 11 Dec 2012 | 8:43 AM ET

    The nation's pension funds and endowments are feeling the pressure of low interest rates on their portfolios. James Bailey, Cambridge Associates co-founder and Janet Cowell, North Carolina State Treasurer, provide perspective.

  • Outlook For the US Economy     Tuesday, 11 Dec 2012 | 8:21 AM ET

    CNBC's Steve Liesman offers insight on the latest Fed survey, including the probability of a recession in the next 12 months.

  • NFIB Optimism Index Falls     Tuesday, 11 Dec 2012 | 7:31 AM ET

    The NFIB Optimism Index shows job creation in November was essentially zero. William Dunkelberg, NFIB chief economist, offers insight.

  • How Will the Fed Replace Operation Twist?     Tuesday, 11 Dec 2012 | 7:27 AM ET

    CNBC's Steve Liesman breaks down the next steps for the Fed according to a CNBC survey. 88 percent of respondents said the Fed will replace Operation Twist with outright asset purchases, he says. Cliff Robbins, CEO of Blue Harbour Group, weighs in.

  • CNBC's "Squawk Box" team and Cliff Robbins, CEO of Blue Harbour Group, speak with Emanuel Chirico, The PVH Group chairman & CEO, about the Warnaco deal.

  • The State of Global Agriculture     Tuesday, 11 Dec 2012 | 6:42 AM ET

    How the U.S. drought is affecting the global agriculture business, and how to play the industry, with Martin Richenhagen, CEO of Agco Corporation.

  • A few early stocks to watch, with the "Squawk Box" team, including Hertz announcing its 3 biggest stockholders are selling 50 million shares

  • Checking Futures Amid Fiscal Cliff Talks     Tuesday, 11 Dec 2012 | 6:33 AM ET

    Forecasting how the fiscal cliff negotiations might impact the futures market for the rest of the week, with Kevin Ferry, Cronus Futures Management.

  • Pre-Market Report: What You Need to Know     Tuesday, 11 Dec 2012 | 6:00 AM ET

    CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S.

  • Mad Money host Jim Cramer explains why he thinks Tupperware is a pristine brand with an amazing balance sheet and a history of beating expectations.

  • Buy Seattle Genetics on Pulback?     Monday, 10 Dec 2012 | 6:45 PM ET

    Clay Siegall, Seattle Genetics, explains how today's medical advances are turning into tomorrow's therapies, with Mad Money's Jim Cramer.

  • Pipeline Prospects With Enbridge CEO     Monday, 10 Dec 2012 | 6:25 PM ET

    Al Monaco, Enbridge president and CEO, discusses his company's plans to increase pipeline capacity from North Dakota to refineries in the Midwest and Canada, with Mad Money host Jim Cramer.

  • Cramer Talks Biotech With ImmunoGen CEO     Monday, 10 Dec 2012 | 6:15 PM ET

    Dan Junius, ImmunoGen CEO, discusses which drugs are in the company's pipeline, and weighs in on the outlook for the company, with Mad Money's Jim Cramer.

  • Cramer Tackles the 'Fiscal Cliff' & Apple     Monday, 10 Dec 2012 | 6:00 PM ET

    Mad Money host Jim Cramer weighs in on whether investors pay too much attention to Apple stock and the "fiscal cliff."